Adial Pharmaceuticals (ADIL)

• Market cap: $2.24M
• 1 day: 1.29%
• 5 days: 0%
• 1 month: -10.29%
• 3 months: -59.95%
• 6 months: -80.69%
• Year to date: -73.75%
• 1 year: -90.89%
• 5 years: -99.89%
• 10 years: -99.94%
• Sector: Healthcare
• Industry: Biotechnology

About: Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.

Employees: 6